Overview

Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This study is to be conducted in subjects with mild-to-moderate COPD who are cigarette smokers with the intent of demonstrating differences in smoking cessation between varenicline and placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Varenicline